Nexalin Technology (NXL) EBT Margin (2021 - 2026)
Nexalin Technology (NXL) posted quarterly EBT Margin of 14025.67% for Q1 2026, down 918039.0% year-over-year from N/an in Q1 2025, and down 914.47% quarter-over-quarter from 1382.56% in Q4 2025.
Nexalin Technology (NXL) EBT Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's EBT Margin history runs 6 years deep, the most recent figure standing at 14025.67% for Q1 2026.
- In Q1 2026, EBT Margin fell 918039.0% year-over-year to 14025.67%; the TTM figure through Mar 2026 stood at 3022.94% (up 349866.0% YoY), while the FY2025 annual figure was 2725.42%, up 178332.0% from the prior year.
- EBT Margin for Q1 2026 stood at 14025.67%, down from 1382.56% in the prior quarter.
- The five-year high for EBT Margin was 55.68% in Q3 2022, with the low at 14025.67% in Q1 2026.
- The 5-year median for EBT Margin is 2449.0% (2023), against an average of 4629.51%.
- The sharpest annual moves came in 2023 and 2025: EBT Margin tumbled 947108 bps in 2023, then jumped 902483 bps in 2025.
- Nexalin Technology's EBT Margin stood at 1974.33% in 2022, then sank by 93 bps to 3801.47% in 2023, then sank by 174 bps to 10407.39% in 2024, then soared by 87 bps to 1382.56% in 2025, then plunged by 914 bps to 14025.67% in 2026.
- Business Quant data shows NXL's EBT Margin at 14025.67% in Q1 2026, 1382.56% in Q4 2025, and 12542.35% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.32% |
| 10 | Nexalin Technology | 7.02 Mn | 6.01 Mn | 8,897.00 | -18,412.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18,412.71% |
| Mar 31, 2026 | -14,025.67% |
| Dec 31, 2025 | -1,382.56% |
| Sep 30, 2025 | -12,542.35% |
| Jun 30, 2025 | -2,239.74% |
| Mar 31, 2025 | -4,845.27% |
| Dec 31, 2024 | -10,407.39% |
| Sep 30, 2024 | -6,795.30% |
| Jun 30, 2024 | -4,780.93% |
| Mar 31, 2024 | -1,330.78% |
| Dec 31, 2023 | -3,801.47% |
| Sep 30, 2023 | -9,526.77% |
| Jun 30, 2023 | -2,314.12% |
| Mar 31, 2023 | -2,449.00% |
| Dec 31, 2022 | -1,974.33% |
| Sep 30, 2022 | -55.68% |
| Jun 30, 2022 | -108.64% |
| Mar 31, 2022 | -121.63% |
| Dec 31, 2021 | -2,483.14% |
| Sep 30, 2021 | -3,256.43% |